SCHEMBL24512661

SCHEMBL24512661

CON(C)C(=O)c1ccc(C(O)c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.48
SRD5A2 P31213 1/20 0.47
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.43
ROCK2 O75116 1/20 0.43
OPRD1 P41143 6/20 0.42
KMT2A Q03164 3/20 0.40
HPGD P15428 1/20 0.40
OPRM1 P35372 1/20 0.39
MEN1 O00255 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
NOD2 Q9HC29 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24512662 0.86 MLYCD (0.47) MLYCDSRD5A2KDM4EALDH1A1ROCK2
SCHEMBL28777 0.82 MLYCD (0.54) MLYCDKDM4EALDH1A1KMT2AHPGD
Hydrochloric Acid SCHEMBL7476159 0.81 MLYCD (0.53) MLYCDKDM4EALDH1A1KMT2AHPGD
SCHEMBL3303829 0.80 HPGD (0.56) MLYCDSRD5A2ALDH1A1KMT2AHPGD
SCHEMBL4449884 0.80 MAPT (0.56) MLYCDKDM4EALDH1A1HPGDMAPT
SCHEMBL19008976 0.80 MLYCD (0.53) MLYCDKDM4EALDH1A1KMT2AHPGD
SCHEMBL16563797 0.78 MLYCD (0.55) MLYCDALDH1A1ROCK2OPRD1KMT2A
SCHEMBL22531823 0.77 MLYCD (0.57) MLYCDSRD5A2KDM4EALDH1A1KMT2A
SCHEMBL19533698 0.77 SMN1; SMN2 (0.59) MLYCDSRD5A2KDM4EALDH1A1KMT2A
SCHEMBL866718 0.76 TSHR (0.64) SRD5A2ALDH1A1ROCK2OPRD1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE PTDSS1, PTDSS2, SMPD1 MLYCD 2576/4885SRD5A2 1650/4885KDM4E 1975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.